Paper39201463
Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies.
Kim HJ and 1 other. Int J Mol Sci, 2024. Cited by 66 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies. Papers, record 39201463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201463
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Keloid | Major topic |
| Humans | |
| Animals | |
| Signal Transduction | |
| Extracellular Matrix | |
| Transforming Growth Factor beta | |
| Wound Healing |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07836569 | Outcomes of the A.S.A.P. Algorithm for Keloids: A Controlled Prospective Study | Background |
Source ClinicalTrials.gov
References268
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26301129 | Surgical Excision with Adjuvant Irradiation for Treatment of Keloid Scars: A Systematic Review. | Plast Reconstr Surg Glob Open | 2015 | https://conductscience.org/library/papers/26301129 | PubMed |
| 2 | 26829033 | IL-6 Polymorphism and Susceptibility to Keloid Formation in a Japanese Population. | J Invest Dermatol | 2016 | https://conductscience.org/library/papers/26829033 | PubMed |
| 3 | 18371435 | Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. | Cell Stem Cell | 2008 | https://conductscience.org/library/papers/18371435 | PubMed |
| 4 | 17024100 | Functional implications of the IL-6 signaling pathway in keloid pathogenesis. | J Invest Dermatol | 2007 | https://conductscience.org/library/papers/17024100 | PubMed |
| 5 | 22954589 | Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. | FASEB J | 2012 | https://conductscience.org/library/papers/22954589 | PubMed |
| 6 | 20711176 | A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. | Nat Genet | 2010 | https://conductscience.org/library/papers/20711176 | PubMed |
| 7 | 27506499 | Keloidectomy with core fillet flap and intralesional verapamil injection for recurrent earlobe keloids. | Indian J Dermatol Venereol Leprol | 2016 | https://conductscience.org/library/papers/27506499 | PubMed |
| 8 | 4877599 | Fluocinolone acetonide 0.2 per cent cream--a co-operative clinical trial. | Br J Dermatol | 1968 | https://conductscience.org/library/papers/4877599 | PubMed |
| 9 | 24478874 | Hypopigmentation and subcutaneous fat, muscle atrophy after local corticosteroid injection. | Korean J Anesthesiol | 2013 | https://conductscience.org/library/papers/24478874 | PubMed |
| 10 | 32205184 | Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway. | Mol Cell Probes | 2020 | https://conductscience.org/library/papers/32205184 | PubMed |
| 11 | 20725565 | Innovative therapies in the treatment of keloids and hypertrophic scars. | J Clin Aesthet Dermatol | 2010 | https://conductscience.org/library/papers/20725565 | PubMed |
| 12 | 12560674 | Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. | Plast Reconstr Surg | 2003 | https://conductscience.org/library/papers/12560674 | PubMed |
| 13 | 22272655 | A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. | Dermatol Surg | 2012 | https://conductscience.org/library/papers/22272655 | PubMed |
| 14 | 26911400 | Verapamil is Less Effective than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial. | Acta Derm Venereol | 2016 | https://conductscience.org/library/papers/26911400 | PubMed |
| 15 | 32537319 | Keloids: Which Types Can Be Excised without Risk of Recurrence? A New Clinical Classification. | Plast Reconstr Surg Glob Open | 2020 | https://conductscience.org/library/papers/32537319 | PubMed |
| 16 | 34357011 | Adjuvant Radiotherapy after Surgical Excision in Keloids. | Medicina (Kaunas) | 2021 | https://conductscience.org/library/papers/34357011 | PubMed |
| 17 | 3470308 | Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3470308 | PubMed |
| 18 | 23249157 | Pulsed dye laser for the treatment of keloid and hypertrophic scars: a systematic review. | Expert Rev Med Devices | 2012 | https://conductscience.org/library/papers/23249157 | PubMed |
| 19 | 345427 | Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. | Scand J Plast Reconstr Surg | 1977 | https://conductscience.org/library/papers/345427 | PubMed |
| 20 | 31961041 | Correlation between serum IL 37 levels with keloid severity. | J Cosmet Dermatol | 2020 | https://conductscience.org/library/papers/31961041 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908757 | Deciphering fibroblast and myeloid-cell states in keloids: an integrative analysis identifies ANKRD1 as a ferroptosis-related candidate gene. | Front Immunol | 2026 | https://conductscience.org/library/papers/42908757 | PubMed |
| 42818600 | HUCMSCs-Derived Exosomes Attenuate Keloid Fibroblast Pathological Phenotypes with Associated Metabolic-Redox-Matrix Network Remodeling: A Proteomic and In Vivo Study. | Balkan Med J | 2026 | https://conductscience.org/library/papers/42818600 | PubMed |
| 42799479 | Identification and Preliminary mRNA Validation of Key Genes Associated with Tolerogenic Dendritic Cells in Keloid Based on Transcriptome Data. | Clin Cosmet Investig Dermatol | 2026 | https://conductscience.org/library/papers/42799479 | PubMed |
| 42792159 | Mitochondrial Transplantation Suppresses mtDNA-cGAS/STING-Mediated Innate Immunity by Enhancing PINK1/Parkin-Dependent Mitophagy to Attenuate Keloid Fibrosis. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792159 | PubMed |
| 42787495 | Endothelial system dysregulation underlies keloid development and therapeutic targeting. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42787495 | PubMed |
| 42770101 | A novel CAVIN1/GAS5 axis suppresses skin fibrosis through mitochondrial fission-mediated attenuation of the TGF-β/Smad pathway. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42770101 | PubMed |
| 42688921 | Mechanistic insights into Strontium-90 superficial radiotherapy in keloids: senescence-associated changes and ECM remodeling across cell-matrix scales. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42688921 | PubMed |
| 42665390 | Gene Expression of TGF-β1, Matrix Metalloproteinases, and Collagen in Keloid Patients and Their Growth Patterns in 2D and 3D Cell Cultures: An In Vitro Study. | In Vivo | 2026 | https://conductscience.org/library/papers/42665390 | PubMed |
| 42657113 | Hydrogel microneedles functioning in pathological surroundings: where soft materials overcome hard scars. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42657113 | PubMed |
| 42436808 | Mitochondria-targeted phototherapeutic system enabling spatiotemporal-controlled NADH depletion for keloid intervention. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42436808 | PubMed |
| 42306298 | Extracellular vesicle-mediated cell-cell communication in keloids and hypertrophic scars: mechanisms, methodological caveats, and therapeutic perspectives. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42306298 | PubMed |
| 42305783 | Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42305783 | PubMed |
| 42212370 | Epigenetic orchestration of scar formation: Therapeutic potential of targeting DNA methylation and non‑coding RNAs in cutaneous fibrosis (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42212370 | PubMed |
| 42195168 | Surgical Excision with Adjuvant Therapies in the Management of Keloids: A Systematic Review. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42195168 | PubMed |
| 42168421 | Effect of Granulocyte Colony-Stimulating Factor (G-CSF) and Botulinum Toxin Type A on Fat Graft Retention in a Rat Model. | Aesthetic Plast Surg | 2026 | https://conductscience.org/library/papers/42168421 | PubMed |
| 42138176 | POSTN(+) fibroblasts and SPP1(+) macrophages in scar formation: A review of mechanisms and therapeutic targets (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42138176 | PubMed |
| 42121883 | Refractory Keloids and Hypertrophic Scars: Immune Dysregulation and Neuroimmune Mechanisms Underlying Treatment Failure. | Cells | 2026 | https://conductscience.org/library/papers/42121883 | PubMed |
| 42112383 | Advances in the interplay between mechanical forces and inflammatory immunity in keloid formation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42112383 | PubMed |
| 42098529 | Research advances in the pathogenesis and photodynamic therapy of pathological scars. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/42098529 | PubMed |
| 42074238 | Exploring the Complexities of TGF-β Signaling in Keloids: Beyond the Classical Smad Pathway. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074238 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201463
GET https://conductscience.org/api/papers/v1/39201463/references?page=2